Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CARM1 | Q86X55 | 2/20 | 0.32 |
| ▸ | PRMT6 | Q96LA8 | 2/20 | 0.32 |
| ▸ | PRMT8 | Q9NR22 | 2/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.31 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.30 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7580225 | 0.91 | ALOX15 (0.62) | ALOX15ACE2CARM1PRMT6PRMT8 | |
| SCHEMBL740177 | 0.83 | — | — | |
| SCHEMBL1863802 | 0.81 | ALOX15 (0.75) | ALOX15ACE2L3MBTL1CARM1PRMT6 | |
| SCHEMBL1612176 | 0.81 | — | — | |
| SCHEMBL28009791 | 0.81 | ALOX15 (0.75) | ALOX15ACE2L3MBTL1CARM1PRMT6 | |
| SCHEMBL3973592 | 0.78 | KEAP1 (0.48) | ALOX15ACE2SIGMAR1KEAP1SMN1; SMN2 | |
| SCHEMBL441180 | 0.78 | — | — | |
| SCHEMBL22691893 | 0.78 | ALOX15 (0.81) | ALOX15ACE2L3MBTL1CARM1PRMT6 | |
| Hydrochloric Acid SCHEMBL3671864 | 0.76 | ALOX15 (0.77) | ALOX15ACE2L3MBTL1CARM1PRMT6 | |
| Hydrochloric Acid SCHEMBL3021853 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070249652-A1 | Phenanthridinium Derivatives as Dna Binding Agents | UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW (GB) | 2007-10-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249652-A1 | Phenanthridinium Derivatives as Dna Binding Agents | DNA2, DDB1, TOP2B | ALOX15 4840/4885ACE2 3797/4885L3MBTL1 2691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.